In my series eight simple reasons to pause before getting an unlicensed stem cell treatment from a non-compliant clinic I have covered the first five: (1) potential loss of insurance coverage for negative outcomes that could cost hundreds of thousands of dollars, (2) failure of patient follow up by the doctors and clinics, (3) exclusion from future clinical trial […]
How do we evaluate a stem cell journal? There is no doubt about it. The stem cell field has captured the imagination of people around the world of all occupations. Scientists themselves are captivated by stem cells. The number of articles on stem cells and the number of journals focused on stem cells are going
Stem cell journal impact factors: how does your favorite stack up? Read More »
A relatively newly recognized, important player in the stem cell field is a molecule called histone H3.3. Histones are key components of chromatin with integral roles in regulating almost all aspects of cell behavior through orchestrating functions such as transcription and chromosome segregation. Histone H3.3 knockout My lab has just (April 9) published new studies
Histone H3.3: giving cells epigenetic flexibility Read More »
Below, guest blogger, John Carbona gives us his account (including pictures) of Day 2 of the Vatican Stem Cell Meeting, which included a talk by Nobel Laureate John Gurdon. Note, you can read John’s post on Day 1 of the meeting including more great pictures here. Friday, April 12, 2012 The Second International Vatican Adult
John Carbona on Day 2 of Vatican Stem Cell Meeting including Gurdon Talk Read More »
I’ve been fortunate to interview some of the greats in the stem cell field for this blog and host debates between key players. Please note that just because I have interviewed folks does not mean I agree with them or that they agree with me. The point is to establish dialogue on key issues. As
Interviews with leaders and top players in the stem cell field Read More »
The Vatican Stem Cell Meeting 2013 has started. We are fortunate to have a guest blogger, John A. Carbona, CEO of BioLife Cell Bank, who is in attendance and kindly is giving us inside coverage of the meeting. Below is a guest blog from John on Day 1 of the meeting. We even have pictures.
Guest blog from inside Vatican Stem Cell Meeting by John Carbona: Day 1 Read More »
The poll I put up asking people their #1 top priority for FDA reform drew relatively big numbers of respondents. Speeding up clinical trials was clearly way out in front at #1. Expanding compassionate use was #2. These were followed by changing policy to no longer define lab-grown stem cells as drugs and FDA being
Results of FDA Reform Poll: speed up clinical trials & expand compassionate use Read More »
The Vatican 2nd Stem Cell Meeting starts tomorrow and by the looks of the schedule, which was just recently posted, it should be a very interesting adult stem cell meeting. The range of speakers runs from patients to celebrity advocates such as Meredith Vieira to Nobel Laureate Dr. John Gurdon to stellar cancer researcher, Ron
Schedule is up for Vatican Stem Cell Meeting Read More »
One of my inspirations as a stem cell blogger was the pioneering Nature blog, the Niche. I was disappointed when it ended in 2009, but it still is a model of what excellence in science blogging is all about. In this piece today, I interview the co-Founder of the Niche, Dr. Natalie DeWitt. DeWitt now
Interview with Natalie DeWitt, Founder of Nature’s pioneering stem cell blog, the Niche Read More »
One of the problems in the stem cell field is that so few doctors have adequate training in stem cells (biology, transplantation, regulatory issues, GMP, ethics, patient rights, etc) and yet they are treating loads of patients in a for-profit setting. This not puts patients at great risk, but also the physicians themselves are putting